Successful Allogeneic Stem Cell Transplantation With a Reduced-Intensity Conditioning in a Case of Leukocyte Adhesion Deficiency Type Iii

Successful Allogeneic Stem Cell Transplantation With a Reduced-Intensity Conditioning in a Case of Leukocyte Adhesion Deficiency Type Iii Publisher

Barhoom D^{1, 2} ; Behfar M¹ ; Mohseni R¹ ; Hamidieh AA¹

Show Affiliations

1. Pediatric Cell and Gene Therapy Research Center, Gene, Cell and Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran
2. Pediatric Hematopoietic Stem Cell Transplant Center, Children's Hospital, Damascus University, Damascus, Syrian Arab Republic

Source: Hematology# Transfusion and Cell Therapy Published:2022

Abstract

[No abstract available]

Related Docs

1. Hematologically Important Mutations: Leukocyte Adhesion Deficiency (Second Update), Blood Cells# Molecules# and Diseases (2023)

2. Allogeneic Hematopoietic Stem Cell Transplantation in Leukocyte Adhesion Deficiency Type I and Iii, Blood Advances (2021)

3. Clinical and Immunological Characteristics of 69 Leukocyte Adhesion Deficiency-I Patients, Pediatric Allergy and Immunology (2023)

4. Leukocyte Adhesion Deficiency Type Iii in an Infant Presenting With Intestinal Perforation and Low Percentage of Natural Killer Cells: First Case Report From Iran, BMC Pediatrics (2025)

5. Investigation of Itgb2 Gene in 12 New Cases of Leukocyte Adhesion Deficiency-Type I Revealed Four Novel Mutations From Iran, Archives of Iranian Medicine (2015)

6. Dual in Vivo T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation With Post-Transplant Cyclophosphamide and Anti-Thymocyte Globulin As a Third Salvage Transplant for Leukocyte Adhesion Deficiency With Graft Failure: A Case Report, Frontiers in Immunology (2024)

7. Fludarabine-Based Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Pediatric Patient With Il10 Receptor Deficiency, Pediatric Transplantation (2021)

8. A Novel Itgb2 Variant in a Patient With Severe Recurrent Pyoderma Gangrenosum-Like Lesions and Underlying Leukocyte Adhesion Deficiency Type I: Case Report and Literature Review, Archives of Dermatological Research (2025)

Experts (# of related papers)

View all Related Experts

Amir Ali Hamidieh (3)

Zahra Pourpak (2)

Style	Citing Format
MLA	Barhoom D, et al.. "Successful Allogeneic Stem Cell Transplantation With a Reduced-Intensity Conditioning in a Case of Leukocyte Adhesion Deficiency Type Iii." Hematology# Transfusion and Cell Therapy, vol. , no. , 2022, pp. -.
APA	Barhoom D, Behfar M, Mohseni R, Hamidieh AA (2022). Successful Allogeneic Stem Cell Transplantation With a Reduced-Intensity Conditioning in a Case of Leukocyte Adhesion Deficiency Type Iii. Hematology# Transfusion and Cell Therapy, (), -.
Chicago	Barhoom D, Behfar M, Mohseni R, Hamidieh AA. "Successful Allogeneic Stem Cell Transplantation With a Reduced-Intensity Conditioning in a Case of Leukocyte Adhesion Deficiency Type Iii." Hematology# Transfusion and Cell Therapy , no. (2022): -.
Harvard	Barhoom D et al. (2022) 'Successful Allogeneic Stem Cell Transplantation With a Reduced-Intensity Conditioning in a Case of Leukocyte Adhesion Deficiency Type Iii', Hematology# Transfusion and Cell Therapy, (), pp. -.
Vancouver	Barhoom D, Behfar M, Mohseni R, Hamidieh AA. Successful Allogeneic Stem Cell Transplantation With a Reduced-Intensity Conditioning in a Case of Leukocyte Adhesion Deficiency Type Iii. Hematology# Transfusion and Cell Therapy. 2022;():-.
BibTex	@article{ author = {Barhoom D and Behfar M and Mohseni R and Hamidieh AA}, title = {Successful Allogeneic Stem Cell Transplantation With a Reduced-Intensity Conditioning in a Case of Leukocyte Adhesion Deficiency Type Iii}, journal = {Hematology# Transfusion and Cell Therapy}, volume = {}, number = {}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Barhoom D AU - Behfar M AU - Mohseni R AU - Hamidieh AA TI - Successful Allogeneic Stem Cell Transplantation With a Reduced-Intensity Conditioning in a Case of Leukocyte Adhesion Deficiency Type Iii JO - Hematology# Transfusion and Cell Therapy VL - IS - SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract